Back to Search
Start Over
Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing.
- Source :
-
Frontiers in immunology [Front Immunol] 2024 Oct 04; Vol. 15, pp. 1470449. Date of Electronic Publication: 2024 Oct 04 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Background: Esophageal cancer (EC) is a major health issue, ranking seventh in incidence and sixth in mortality worldwide. Despite advancements in multidisciplinary treatment approaches, the 5-year survival rate for EC remains low at 21%. Challenges in EC treatment arise from late-stage diagnosis, high malignancy, and poor prognosis. Understanding the tumor microenvironment is critical, as it includes various cellular and extracellular components that influence tumor behavior and treatment response. Mast cells (MCs), as tissue-resident immune cells, play dual roles in tumor dynamics. High-throughput single-cell RNA sequencing offers a powerful tool for analyzing tumor heterogeneity and immune interactions, although its application in EC is limited.<br />Methods: In this study, we investigated the immune microenvironment of EC using single-cell RNA sequencing and established a comprehensive immune profile. We also performed analysis of upstream transcription factors and downstream pathway enrichment to further comprehensively decipher MCs in EC. Besides, we performed knockdown experiments to explore the role of epidermal growth factor receptor ( EGFR ) signaling pathway in MCs-tumor cell interactions, highlighting its potential as a prognostic marker. Finally, we constructed a prognostic model for EC, which provided valuable suggestions for the diagnosis and prognosis of EC.<br />Results: Our analysis identified 11 major cell types, of which MCs were particularly present in pericarcinoma tissues. Further grouping of the 5,001 MCs identified 8 distinct subtypes, including SRSF7 -highly expressed MCs, which showed strong tumor preference and potential tumor-promoting properties. Moreover, we identified the key signaling receptor EGFR and validated it by in vitro knockdown experiments, demonstrating its cancer-promoting effects. In addition, we established an independent prognostic indicator, SRSF7 + MCs risk score (SMRS), which showed a correlation between high SMRS group and poor prognosis.<br />Conclusion: These findings illuminate the complex interactions within the tumor microenvironment of EC and suggest that targeting specific MCs subtypes, particularly via the EGFR signaling pathway, may present novel therapeutic strategies. This study establishes a comprehensive immune map of EC, offering insights for improved treatment approaches.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Zhang, Zhang, Xiahou, Zuo, Xue and Zhang.)
- Subjects :
- Humans
Prognosis
ErbB Receptors genetics
ErbB Receptors metabolism
Signal Transduction
Gene Expression Regulation, Neoplastic
Biomarkers, Tumor genetics
Sequence Analysis, RNA
Male
Female
RNA-Seq
Gene Expression Profiling
Cell Line, Tumor
Esophageal Neoplasms immunology
Esophageal Neoplasms genetics
Esophageal Neoplasms mortality
Mast Cells immunology
Mast Cells metabolism
Tumor Microenvironment immunology
Tumor Microenvironment genetics
Single-Cell Analysis methods
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 15
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 39430754
- Full Text :
- https://doi.org/10.3389/fimmu.2024.1470449